Laporan Kasus: Drug-Induced Liver Injury (Dili) pada Anak

Key Takeaways for GI Nurses

• Drug-induced liver injury (DILI) can occur in pediatric patients and requires heightened awareness during medication history assessment and patient monitoring
• Early recognition of DILI symptoms is crucial for preventing progression to severe hepatotoxicity, making thorough patient assessment skills essential
• Comprehensive medication reconciliation becomes critical when caring for pediatric patients with unexplained liver dysfunction or elevated liver enzymes
• Case-based learning from pediatric DILI presentations enhances clinical decision-making skills for nurses working with young patients in GI settings

Clinical Relevance

This case report highlights the importance of drug-induced liver injury awareness in pediatric gastroenterology practice. For GI nurses, this translates to enhanced vigilance during pre-procedure assessments and post-procedure monitoring. When caring for pediatric patients presenting with liver dysfunction, nurses must maintain a high index of suspicion for medication-related causes, even with commonly prescribed drugs that may seem benign. This requires developing expertise in pediatric-specific medication histories and understanding age-related differences in drug metabolism and hepatotoxicity risk.

The nursing implications extend beyond direct patient care to family education and interdisciplinary communication. GI nurses play a pivotal role in educating families about medication safety, proper dosing, and early warning signs of liver injury. This case underscores the need for nurses to collaborate effectively with pharmacists, pediatric gastroenterologists, and primary care providers to ensure comprehensive medication management. Additionally, documentation of detailed medication histories, including over-the-counter medications, herbal supplements, and dosing patterns, becomes paramount in identifying potential DILI cases.

From a unit operations perspective, this case reinforces the importance of having standardized protocols for pediatric patients with suspected liver injury. GI nurses should be prepared to facilitate rapid diagnostic workups, coordinate care between specialties, and provide appropriate monitoring for patients with evolving hepatotoxicity. The case also emphasizes the value of continuing education focused on pediatric pharmacology and liver injury recognition to maintain competency in this specialized area of practice.

Bottom Line

This pediatric DILI case serves as a critical reminder that drug-induced liver injury can affect patients of all ages, requiring GI nurses to maintain heightened awareness during medication assessment, implement thorough monitoring protocols, and prioritize family education about medication safety to prevent potentially serious hepatotoxic complications in young patients.